Positive inotropic effects of carbon monoxide-releasing molecules (CO-RMs) in the isolated perfused rat heart

Br J Pharmacol. 2006 Dec;149(8):1104-12. doi: 10.1038/sj.bjp.0706939. Epub 2006 Oct 23.

Abstract

Background and purpose: Carbon monoxide (CO) generated by the enzyme haeme oxygenase-1 (HO-1) during the breakdown of haeme is known to mediate a number of biological effects. Here, we investigated whether CO liberated from two water soluble carbon monoxide-releasing molecules (CO-RMs) exerts inotropic effects on the myocardium.

Experimental approach: Rat isolated hearts perfused either at constant flow or constant pressure were used to test the effect of CO-RMs.

Key results: CORM-3, a fast CO releaser, produced a direct positive inotropic effect when cumulative doses (3, 10 and 30 microg min(-1)) or a single dose (5 microM) were infused at either constant coronary pressure (CCP) or constant coronary flow (CCF). The inotropic effect mediated by CORM-3 was abolished by blockade of soluble guanylate cyclase or Na(+)/H(+) exchanger, but not by inhibitors of L-type Ca(2+) channels and protein kinase C. CORM-3 also caused a slight reduction in heart rate but did not alter coronary flow. In contrast, the slow CO releaser CORM-A1 produced significant coronary vasodilatation when given at the highest concentration (30 mug min(-1)) but exerted no effect on myocardial contractility or heart rate.

Conclusion and implications: A rapid CO release from CORM-3 exerts a direct positive inotropic effect on rat isolated perfused hearts, whereas CO slowly released by CORM-A1 had no effect on myocardial contractility but caused significant coronary vasodilatation. Both cGMP and Na(+)/H(+) exchange appear to be involved in this effect but further work is needed to determine the relative contribution of each pathway in CO-mediated inotropic effect.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkaloids / pharmacology
  • Amiloride / analogs & derivatives
  • Amiloride / pharmacology
  • Animals
  • Benzophenanthridines / pharmacology
  • Boranes / metabolism
  • Boranes / pharmacology*
  • Calcium Channel Blockers / pharmacology
  • Carbon Monoxide / metabolism*
  • Carbonates / metabolism
  • Carbonates / pharmacology*
  • Cardiotonic Agents / pharmacology*
  • Enzyme Inhibitors / pharmacology
  • Heart / drug effects
  • Kinetics
  • Male
  • Myocardium / metabolism*
  • Nifedipine / pharmacology
  • Organometallic Compounds / pharmacology*
  • Rats
  • Rats, Inbred Lew
  • Signal Transduction / drug effects

Substances

  • Alkaloids
  • Benzophenanthridines
  • Boranes
  • Calcium Channel Blockers
  • Carbonates
  • Cardiotonic Agents
  • Enzyme Inhibitors
  • Organometallic Compounds
  • sodium boranocarbonate
  • tricarbonylchloro(glycinato)ruthenium(II)
  • Amiloride
  • Carbon Monoxide
  • chelerythrine
  • Nifedipine
  • ethylisopropylamiloride